InvestorsHub Logo
Followers 183
Posts 25188
Boards Moderated 14
Alias Born 04/03/2002

Re: jedijazz post# 196

Tuesday, 03/24/2020 3:33:32 PM

Tuesday, March 24, 2020 3:33:32 PM

Post# of 3813
Sharp gains on CURR today as more investors are starting to recognize the high revenue and earnings potential of the advanced drug delivery and product lines here and how well they are positioned to meet the expanding needs of the global marketplace.

About CURE Pharmaceutical
CURE Pharmaceutical® is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has an FDA- and DEA- registered, cGMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform. CUREform includes CUREfilm®, one of the most advanced oral thin films on the market today; microCURE™, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods™ a novel chewable delivery system. CUREform's combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. CURE partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S, Canada, Israel, and other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.

For more information about CURE Pharmaceutical, please visit its website at http://www.curepharma.com.